{"id":96,"date":"2015-08-05T18:29:19","date_gmt":"2015-08-05T16:29:19","guid":{"rendered":"http:\/\/registre-tumeurs-29.fr\/?page_id=96"},"modified":"2023-02-06T22:22:12","modified_gmt":"2023-02-06T21:22:12","slug":"articles-originaux","status":"publish","type":"page","link":"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/publications\/articles-originaux\/","title":{"rendered":"Articles originaux"},"content":{"rendered":"<p>Badic B, Morvan M, Qu\u00e9n\u00e9herv\u00e9 L, Bouzeloc S, Kermarrec T, Nousbaum JB, Reboux N.\u00a0Real World Data for Pancreatic Adenocarcinoma from a Population-Based Study in France.\u00a0Cancers (Basel). 2023 Jan 15;15(2):525. doi: 10.3390\/cancers15020525.<br \/>PMID: 36672474 (<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36672474\/\">Pubmed<\/a>)<\/p>\n<p>Badic B, Bouvier AM, Bouvier V, Morvan M, Jooste V, Alves A, Nousbaum JB, Reboux N. Predictors of Survival in Elderly Patients with Metastatic Colon Cancer: A Population-Based Cohort Study.\u00a0Cancers (Basel). 2022 Oct 24;14(21):5208. doi: 10.3390\/cancers14215208.\u00a0PMID: 36358628 (<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36358628\/\">Pubmed<\/a>)<\/p>\n<p>Reboux N, Jooste V, Goungounga J, Robaszkiewicz M, Nousbaum JB, Bouvier AM. Incidence and Survival in Synchronous and Metachronous Liver Metastases From Colorectal Cancer.\u00a0JAMA Netw Open. 2022 Oct 3;5(10):e2236666. doi: 10.1001\/jamanetworkopen.2022.36666.\u00a0PMID: 36239935 (<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36239935\/\">Pubmed<\/a>)<\/p>\n<p>Reboux N, Cadieu E, Pruvost-Couvreur M, Cariou M, Kermarrec M, Kermarrec T, Bouzeloc S, Nousbaum JB, Robaszkiewicz M, Qu\u00e9n\u00e9herv\u00e9 L. Factors associated with non-presentation in a multidisciplinary team meeting for colon cancer: A matched retrospective cohort study in a French area.\u00a0Clin Res Hepatol Gastroenterol. 2022 Oct;46(8):101950. doi: 10.1016\/j.clinre.2022.101950. Epub 2022 May 21.\u00a0PMID: 35609825 (<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35609825\/\">Pubmed<\/a>)<\/p>\n<p>Badic B, Oguer M, Cariou M, Kermarrec T, Bouzeloc S, Nousbaum JB, Robaszkiewicz M, Qu\u00e9n\u00e9herv\u00e9 L. Ostomy prevalence and survival in elderly patients with stage III and IV rectal cancer. Geriatr Gerontol Int. <strong>2021<\/strong>;21(8):670-675. PMID: 34189871 (<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34189871\/\">Pubmed<\/a>)<\/p>\n<p>Bocciarelli C, Caumont C, Samaison L, Cariou M, Aline-Fardin A, Doucet L, Roudi\u00e9 J, Terris B, Merlio JP, Marcorelles P, Cappellen D, Uguen A. MSI-High RAS-BRAF wild-type colorectal adenocarcinomas with MLH1 loss have a high frequency of targetable oncogenic gene fusions whose diagnoses are feasible using methods easy-to-implement in pathology laboratories. Hum Pathol. <strong>2021<\/strong>;114:99-109. PMID: 34019865 (<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34019865\/\">Pubmed<\/a>)<\/p>\n<p>Tron L<span class=\"authors-list-item \"><span class=\"comma\">, Fauvernier M, Bouvier AM, Robaszkiewicz M, Bouvier V, Cariou M, Jooste V, Dejardin O, Remontet L, Alves A, Francim Group, Molini\u00e9 F, Launoy G. Socioeconomic environment and survival in patients with digestive cancers: a French population-based study. Cancers (Basel). <strong>2021<\/strong>;13(20):5156. PMID: 34680305 (<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34680305\/\">Pubmed<\/a>)<\/span><\/span><\/p>\n<p>Thomas F, Bouvier AM, Cariou M, Bouvier V, Jooste V, Pouchucq C, Gardy J, Qu\u00e9n\u00e9herv\u00e9 L, Launoy G, Alves A, Eid Y, Dejardin O. Influence of non-clinical factors on restorative rectal cancer surgery: an analysis of four specialized population-based digestive cancer registries in France. Dig Liver Dis. <strong>2021<\/strong>;S1580-8658(21)00364-9. PMID: 34301489 (<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34301489\/\">Pubmed<\/a>)<\/p>\n<ul id=\"full-view-identifiers\" class=\"identifiers\"><\/ul>\n<p>Bouvier AM, Jooste V, Sanchez-Perez MJ, Bento MJ, Rocha Rodrigues J, Marcos-Gragera R, Carmona-Garcia MC, Luque-Fernandez MA, Minicozzi P, Bouvier V, Innos K, Sant M; Working Group on Colorectum. Differences in the management and survival of metastatic colorectal cancer in Europe. A population-based study. Dig Liver Dis. <strong>2021<\/strong>;53:639-645.\u00a0PMID: 33637435 (<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33637435\/\" target=\"_blank\" rel=\"noopener noreferrer\">Pubmed<\/a>)<\/p>\n<p>Badic B, Oguer M, Cariou M, Kermarrec T, Bouzeloc S, Nousbaum JB, Robaszkiewicz M, Queneherve L. Prognostic factors for stage III colon cancer in patients 80 years of age and older. Int J Colorectal Dis. <strong>2021<\/strong>;36:811-819.\u00a0PMID: 33528749 (<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33528749\/\" target=\"_blank\" rel=\"noopener noreferrer\">Pubmed<\/a>)<\/p>\n<p>Defossez G, Uhry Z, Delafosse P, Dantony E, d&rsquo;Almeida T, Plouvier S, Bossard N, Bouvier AM, Molini\u00e9 F, Woronoff AS, Colonna M, Grosclaude P, Remontet L, Monnereau A; French Network of Cancer Registries (FRANCIM).Cancer incidence and mortality trends in France over 1990-2018 for solid tumors: the sex gap is narrowing.\u00a0BMC Cancer. 2021 Jun 24;21(1):726. doi: 10.1186\/s12885-021-08261-1.\u00a0PMID: 34167516 (<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34167516\/\">Pubmed<\/a>)<\/p>\n<p>Mulliri A, Gardy J, Cariou M, Launoy G, Robaszkiewicz M, Alves A, Bouvier V, Dejardin O. Care Management and Survival of Patients Diagnosed with Synchronous Metastatic Colorectal Cancer: A High-Resolution Population-Based Study in Two French Areas.\u00a0Cancers (Basel). 2022 Mar 31;14(7):1777. doi: 10.3390\/cancers14071777.<br \/>PMID: 35406549 (<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35406549\/\">Pubmed<\/a>)<\/p>\n<p>Cariou M, El Fettouhi A, Kermarrec T, Bommelaere F, Foll Y, Nousbaum JB, Robaszkiewicz M, Qu\u00e9n\u00e9herv\u00e9 L. Comparative evaluation of two colorectal cancer screening campaigns using different faecal occult blood tests in a French area. Cancer Epidemiol. <strong>2020<\/strong>;69:101839.\u00a0PMID: 33096500 <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33096500\/\" target=\"_blank\" rel=\"noopener noreferrer\">(Pubmed)<\/a><\/p>\n<p>Bourhis A, De Luca C, Cariou M, Vigliar E, Barel F, Conticelli F, Marcorelles P, Nousbaum JB, Robaszkiewicz M, Samaison L, Badic B, Doucet L, Troncone G, Uguen A. Evaluation of KRAS, NRAS and BRAF mutational status and microsatellite instability in early colorectal carcinomas invading the submucosa (pT1): towards an in-house molecular prognostication for pathologists? J Clin Pathol. <strong>2020<\/strong>: jclinpath-2020-206496. (<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32273401\/?from_single_result=PMID%3A+32273401&amp;expanded_search_query=PMID%3A+32273401\" target=\"_blank\" rel=\"noopener noreferrer\">Pubmed<\/a>)<\/p>\n<p>Bouvier AM, Robaszkiewicz M, Jooste V, Cariou M, Drouillard A, Bouvier V, Nousbaum JB and The French Network of Cancer Registries (FRANCIM). Trends in incidence of small bowel cancer according to histology: a population-based study. J\u00a0Gastroenterol <strong>2020<\/strong>;\u00a055: 181-8. (<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31630251\/\" target=\"_blank\" rel=\"noopener noreferrer\">Pubmed<\/a>)<\/p>\n<p>Cowppli-Bony A, Colonna M, Ligier K, Jooste V, Defossez G, Monnereau A, le R\u00e9seau Francim, R\u00e9seau des registres de cancer Francim.\u00a0Descriptive Epidemiology of Cancer in Metropolitan France: Incidence, Survival and Prevalence. Bull Cancer <strong>2019<\/strong>;\u00a0106: 617-34 (<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30833045\/\" target=\"_blank\" rel=\"noopener noreferrer\">Pubmed<\/a>)<\/p>\n<p>Barel F, Cariou M, Saliou P, Kermarrec T, Auffret A ,Samaison L , Bourhis A, Badic B, J\u00e9z\u00e9quel J, Cholet F, Bail JP, Marcorelles P, Nousbaum JB, Robaszkiewicz M, Doucet L, Uguen A. Histopathological factors help to predict lymph node metastases more efficiently than extra-nodal recurrences in submucosa invading pT1 colorectal cancer. Sci Rep. <strong>2019<\/strong>;9:8342. (<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31171832\/\" target=\"_blank\" rel=\"noopener noreferrer\">Pubmed<\/a>)<\/p>\n<p>Barel F, Auffret A, Cariou M, Kermarrec T, \u00a0Samaison L , Bourhis A, Badic B, J\u00e9z\u00e9quel J, Cholet F, Bail JP, Marcorelles P, Nousbaum JB, Robaszkiewicz M, Doucet L, Uguen A. High Reproducibility Is Attainable in Assessing Histoprognostic Parameters of pT1 Colorectal Cancer Using Routine Histopathology Slides and Immunohistochemistry Analyses.\u00a0Pathology <strong>2019<\/strong>;\u00a051: 46-54. (<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30477880\" target=\"_blank\" rel=\"noopener noreferrer\">Pubmed<\/a>)<\/p>\n<p>Arnachellum R, Cariou M, Nousbaum JB, Jezequel J, Le Reste JY, Robaszkiewicz M.\u00a0Pancreatic adenocarcinoma in the Finistere\u00a0department, France, between 2002 and 2011 (1002 cases): population characteristics, treatment and survival. Pancreas. <strong>2016<\/strong>;45:953-60 <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26765965\" target=\"_blank\" rel=\"noopener noreferrer\">(Pubmed)<\/a><\/p>\n<p>Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, Bannon F, Ahn JV, Johnson CJ, Bonaventure A, Marcos-Gragera R, Stiller C, Azevedo e Silva G, Chen WQ, Ogunbiyi OJ, Rachet B, Soeberg MJ, You H, Matsuda T, Bielska-Lasota M, Storm H, Tucker TC, Coleman MP; CONCORD Working Group. Global surveillance of cancer survival 1995\u20132009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet <strong>2015<\/strong>; 385: 977-1010. <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25467588\" target=\"_blank\" rel=\"noopener noreferrer\">(PubMed)<\/a><\/p>\n<p>Gattolliat CH, Uguen A, Pesson M, Trillet K, Simon B, Doucet L, Robaszkiewicz M, Corcos L. MicroRNA and targeted mRNA expression profiling analysis in human colorectal adenomas and adenocarcinomas. Eur J Cancer. <strong>2015<\/strong> Feb;51(3):409-20. <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25586944\" target=\"_blank\" rel=\"noopener noreferrer\">(PubMed)<\/a><\/p>\n<p>Desgrippes R, Bouvier V, Delafosse P, Robaszkiewicz M, Molini\u00e9 F, Tr\u00e9tarre B, Lepage C, Faivre J, Jooste V, Bouvier AM. Management of rectal cancer in France in a well-defined population. Eur J Gastroenterol Hepatol. <strong>2014<\/strong> Jul;26(7):743-7. <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24802250\" target=\"_blank\" rel=\"noopener noreferrer\">(PubMed)<\/a><\/p>\n<p>Pesson M, Volant A, Uguen A, Trillet K, De La Grange P, Aubry M, Daoulas M, Robaszkiewicz M, Le Gac G, Morel A, Simon B, Corcos L. A gene expression and pre-mRNA splicing signature that marks the adenoma-adenocarcinoma progression in colorectal cancer. PLoS One. <strong>2014<\/strong> Feb 6;9(2):e87761. <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24516561\" target=\"_blank\" rel=\"noopener noreferrer\">(PubMed)<\/a><\/p>\n<p>Binder-Foucard F, Bossard N, Delafosse P, Belot A, Woronoff AS, Remontet L; French network of cancer registries (Francim). Cancer incidence and mortality in France over the 1980-2012 period: solid tumors. Rev Epidemiol Sante Publique. <strong>2014<\/strong>;62:95-108. <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24613140\" target=\"_blank\" rel=\"noopener noreferrer\">(Pubmed)<\/a><\/p>\n<p>Bouvier AM, Arveux P, Baldi I, Bouvier V, Dabakuyo S, Daoulas M et al. Quels sont les d\u00e9lais de prise en charge des cancers en france ? Etude men\u00e9e \u00e0 partir des registres de cancers. Bull Epidemiol Hebd. <strong>2013<\/strong>;43-44-45: 581-9.<\/p>\n<p><strong>ETUDES\u00a0EUROCARE<\/strong><\/p>\n<p>Gatta G, Capocaccia R, Botta L, Mallone S, De Angelis R, Ardanaz E, et al.\u00a0RARECAREnet working group.\u00a0Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study.\u00a0Lancet Oncol. <strong>2017<\/strong>; 4. pii: S1470-2045 <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28687376\" target=\"_blank\" rel=\"noopener noreferrer\">(Pubmed)<\/a><\/p>\n<p>De Angelis R,, Minicozzi P, Sant M, Dal Maso L, Brewster DH, Osca-Gelis G, et al.\u00a0Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000-2007: Results of EUROCARE-5 population-based study.Eur J Cancer. <strong>2015<\/strong>;51:2254-2268.<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26421827\" target=\"_blank\" rel=\"noopener noreferrer\">(Pubmed)<\/a><\/p>\n<p>Francisci S, Minicozzi P, Pierannunzio D, Ardanaz E, Eberle A, Grimsrud TK, et al.\u00a0EUROCARE-5 Working Group.\u00a0Survival patterns in lung and pleural cancer in Europe 1999-2007: Results from the EUROCARE-5 study.\u00a0Eur J Cancer. <strong>2015<\/strong>;51:2242-2253. <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26421826\" target=\"_blank\" rel=\"noopener noreferrer\">(Pubmed)<\/a><\/p>\n<p>Visser O, Ardanaz E, Botta L, Sant M, Tavilla A, Minicozzi P; EUROCARE-5 Working Group:.Survival of adults with primary malignant brain tumours in Europe; Results of the EUROCARE-5 study. \u00a0Eur J Cancer. <strong>2015<\/strong>;51:2231-2241.<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26421825\" target=\"_blank\" rel=\"noopener noreferrer\"> (Pubmed)<\/a><\/p>\n<p>Marcos-Gragera R, Mallone S, Kiemeney LA, Vilardell L, Malats N, Allory Y, Sant M; EUROCARE-5 Working Group.\u00a0Urinary tract cancer survival in Europe 1999-2007: Results of the population-based study EUROCARE-5.\u00a0Eur J Cancer. <strong>2015<\/strong>;51:2217-2230. <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26421824\" target=\"_blank\" rel=\"noopener noreferrer\">(Pubmed)<\/a><\/p>\n<p>Trama A, Foschi R, Larra\u00f1aga N, Sant M, Fuentes-Raspall R, Serraino D, et al.; EUROCARE-5 Working Group.\u00a0Survival of male genital cancers (prostate, testis and penis) in Europe 1999-2007: Results from the EUROCARE-5 study.Eur J Cancer. <strong>2015<\/strong> ;51:2206-2216. <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26421823\" target=\"_blank\" rel=\"noopener noreferrer\">(Pubmed)<\/a><\/p>\n<p>Sant M, Chirlaque Lopez MD, Agresti R, S\u00e1nchez P\u00e9rez MJ, Holleczek B, Bielska-Lasota M,et al.\u00a0; EUROCARE-5 Working Group.\u00a0Survival of women with cancers of breast and genital organs in Europe 1999-2007: Results of the EUROCARE-5 study.\u00a0Eur J Cancer. <strong>2015<\/strong>;51:2191-2205. <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26421822\" target=\"_blank\" rel=\"noopener noreferrer\">(Pubmed)<\/a><\/p>\n<p>Crocetti E, Mallone S, Robsahm TE, Gavin A, Agius D, Ardanaz E, et al.; EUROCARE-5 Working Group.\u00a0Survival of patients with skin melanoma in Europe increases further: Results of the EUROCARE-5 study.\u00a0Eur J Cancer. <strong>2015<\/strong>;51:2179-2190. <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26421821\" target=\"_blank\" rel=\"noopener noreferrer\">(Pubmed)<\/a><\/p>\n<p>Lepage C, Capocaccia R, Hackl M, Lemmens V, Molina E, Pierannunzio D, Sant M, Trama A, Faivre J; EUROCARE-5 Working Group.\u00a0Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999-2007: Results of EUROCARE-5.\u00a0Eur J Cancer. <strong>2015<\/strong> ;51:2169-2178.<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26421820\" target=\"_blank\" rel=\"noopener noreferrer\"> (Pubmed)<\/a><\/p>\n<p>Holleczek B, Rossi S, Domenic A, Innos K, Minicozzi P, Francisci Set al.; EUROCARE-5 Working Group.\u00a0On-going improvement and persistent differences in the survival for patients with colon and rectum cancer across Europe 1999-2007 &#8211; Results from the EUROCARE-5 study.\u00a0Eur J Cancer. <strong>2015<\/strong>;51:2158-2168. <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26421819\" target=\"_blank\" rel=\"noopener noreferrer\">(Pubmed)<\/a><\/p>\n<p>Anderson LA, Tavilla A, Brenner H, Luttmann S, Navarro C, Gavin AT, et al.; EUROCARE-5 Working Group .\u00a0Survival for oesophageal, stomach and small intestine cancers in Europe 1999-2007: Results from EUROCARE-5.\u00a0Eur J Cancer. <strong>2015<\/strong>;51:2144-2157.<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26421818\" target=\"_blank\" rel=\"noopener noreferrer\"> (Pubmed)<\/a><\/p>\n<p>Gatta G, Botta L, S\u00e1nchez MJ, Anderson LA, Pierannunzio D, Licitra L; EUROCARE Working Group.\u00a0Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study.\u00a0Eur J Cancer. <strong>2015<\/strong>;51:2130-2143. <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26421817\" target=\"_blank\" rel=\"noopener noreferrer\">(Pubmed)<\/a><\/p>\n<p>Baili P, Di Salvo F, Marcos-Gragera R, Siesling S, Mallone S, Santaquilani M, et al.; EUROCARE-5 Working Group.\u00a0Age and case mix-standardised survival for all cancer patients in Europe 1999-2007: Results of EUROCARE-5, a population-based study.\u00a0Eur J Cancer. <strong>2015<\/strong>;51:2120-2129. <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26421816\" target=\"_blank\" rel=\"noopener noreferrer\">(Pubmed)<\/a><\/p>\n<p>Rossi S, Baili P, Capocaccia R, Caldora M, Carrani E, Minicozzi P, et al.\u00a0; EUROCARE-5 Working Group. The EUROCARE-5 study on cancer survival in Europe 1999-2007: Database, quality checks and statistical analysis methods.Eur J Cancer. <strong>2015<\/strong>;51:2104-2119.<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26421815\" target=\"_blank\" rel=\"noopener noreferrer\"> (Pubmed)<\/a><\/p>\n<p>Minicozzi P, Bouvier AM, Faivre J, Sant M; Study working group.\u00a0Management of rectal cancers in relation to treatment guidelines: a population-based study comparing Italian and French patients.\u00a0Dig Liver Dis. <strong>2014<\/strong>;46:645-51. <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24746280\" target=\"_blank\" rel=\"noopener noreferrer\">(Pubmed)<\/a><\/p>\n<p>De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, et al.; EUROCARE-5 Working Group. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE&#8211;5-a population-based study.\u00a0Lancet Oncol. <strong>2014<\/strong>;15:23-34. <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24314615\" target=\"_blank\" rel=\"noopener noreferrer\">(Pubmed)<\/a><\/p>\n<p><strong>ETUDES RARECARE<\/strong><\/p>\n<p>Lykoudis PM, Partelli S, Muffatti F, et al. Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours. Eur J Surg Oncol. 2019;45(1):46\u201351. (<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29126671\/\">Pubmed<\/a>)\u00a0Imbimbo M, Maury JM, Garassino M, Girard N; RARECAREnet Working Group. Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting. <i>Eur J Surg Oncol<\/i>. <strong>2019<\/strong>;45(1):75\u201380. (<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29426781\/\">Pubmed<\/a>)<\/p>\n<p>Ray-Coquard I, Trama A, Seckl MJ, et al. Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting. Eur J Surg Oncol. <strong>2019<\/strong>;45(1):67\u201374. (<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29108961\/\">Pubmed<\/a>)<\/p>\n<p>Gatta G, Trama A, Capocaccia R; RARECARENet Working Group. Epidemiology of rare cancers and inequalities in oncologic outcomes. Eur J Surg Oncol. <strong>2019<\/strong>;45(1):3\u201311. (<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29032924\/\">Pubmed<\/a>)<\/p>\n<p>Pasquali S, Bonvalot S, Tzanis D, et al. Treatment challenges in and outside a network setting: Soft tissue sarcomas. Eur J Surg Oncol. <strong>2019<\/strong>;45(1):31\u201339. (<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28985973\/\">Pubmed<\/a>)<\/p>\n<p>Gatta G, Capocaccia R, Botta L, et al. Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study [published correction appears in Lancet Oncol. 2017 Aug;18(8):e433]. <i>Lancet Oncol<\/i>. <strong>2017<\/strong>;18(8):1022\u20131039. (<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28687376\/\">Pubmed<\/a>)<\/p>\n<p><strong>ETUDES GROUPE EUROPEEN D&rsquo;ETUDES HAUTE RESOLUTION SUR LE CANCER COLORECTAL<\/strong><\/p>\n<p>Cardoso R, Guo F, Heisser T, De Schutter H, Van Damme N, Nilbert MC, Christensen J, Bouvier AM, Bouvier V, Launoy G, Woronoff AS, Cariou M, Robaszkiewicz M, Delafosse P, Poncet F, Walsh PM, Senore C, Rosso S, Lemmens VEPP, Elferink MAG, Tom\u0161i\u010d S, \u017dagar T, Marques ALM, Marcos-Gragera R, Puigdemont M, Galceran J, Carulla M, S\u00e1nchez-Gil A, Chirlaque MD, Hoffmeister M, Brenner H.Overall and stage-specific survival of patients with screen-detected colorectal cancer in European countries: A population-based study in 9 countries.\u00a0Lancet Reg Health Eur. 2022 Jul 6;21:100458. doi: 10.1016\/j.lanepe.2022.100458. eCollection 2022 Oct.\u00a0PMID: 35832063 (<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35832063\/\">Pubmed<\/a>)<\/p>\n<p>Cardoso R, Guo F, Heisser T, De Schutter H, Van Damme N, Nilbert MC, Tybjerg AJ, Bouvier AM, Bouvier V, Launoy G, Woronoff AS, Cariou M, Robaszkiewicz M, Delafosse P, Poncet F, Walsh PM, Senore C, Rosso S, Lemmens VEPP, Elferink MAG, Tom\u0161i\u010d S, \u017dagar T, Lopez de Munain Marques A, Marcos-Gragera R, Puigdemont M, Galceran J, Carulla M, S\u00e1nchez-Gil A, Chirlaque MD, Hoffmeister M, Brenner H.Proportion and stage distribution of screen-detected and non-screen-detected colorectal cancer in nine European countries: an international, population-based study.\u00a0Lancet Gastroenterol Hepatol. 2022 Aug;7(8):711-723. doi: 10.1016\/S2468-1253(22)00084-X. Epub 2022 May 11.\u00a0PMID: 35561739 (<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35561739\/\">Pubmed<\/a>)<\/p>\n<p>Cardoso R, Guo F, Heisser T, Hackl M, Ihle P, De Schutter H, Van Damme N, Valerianova Z, Atanasov T et al. Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study. <strong>2021<\/strong>;22(7):1002-1013. PMID: 34048685 (<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34048685\/\">Pubmed<\/a>)<\/p>\n<p>Minicozzi P, Vicentini M, Innos K, Castro C, Guevara M, Stracci F, et al. European HR Working Group on colorectal cancer. Comorbidities, timing of treatments, and chemotherapy use influence outcomes in stage III colon cancer: A population-based European study. Eur J Surg Oncol. <strong>2020<\/strong> Feb 21:S0748-7983(20)30125-6. (<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32147427\/\">Pubmed<\/a>)<\/p>\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Badic B, Morvan M, Qu\u00e9n\u00e9herv\u00e9 L, Bouzeloc S, Kermarrec T, Nousbaum JB, Reboux N.\u00a0Real World Data for Pancreatic Adenocarcinoma from a Population-Based Study in France.\u00a0Cancers (Basel). 2023 Jan 15;15(2):525. doi: 10.3390\/cancers15020525.PMID: 36672474 (Pubmed) Badic B, Bouvier AM, Bouvier V, Morvan M, Jooste V, Alves A, Nousbaum JB, Reboux N. Predictors of Survival in Elderly Patients [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":90,"menu_order":1,"comment_status":"closed","ping_status":"open","template":"","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":[],"rop_publish_now_history":[],"rop_publish_now_status":"pending","_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"class_list":["post-96","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Articles originaux - REGISTRE DES TUMEURS DIGESTIVES DU FINISTERE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/publications\/articles-originaux\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Articles originaux - REGISTRE DES TUMEURS DIGESTIVES DU FINISTERE\" \/>\n<meta property=\"og:description\" content=\"Badic B, Morvan M, Qu\u00e9n\u00e9herv\u00e9 L, Bouzeloc S, Kermarrec T, Nousbaum JB, Reboux N.\u00a0Real World Data for Pancreatic Adenocarcinoma from a Population-Based Study in France.\u00a0Cancers (Basel). 2023 Jan 15;15(2):525. doi: 10.3390\/cancers15020525.PMID: 36672474 (Pubmed) Badic B, Bouvier AM, Bouvier V, Morvan M, Jooste V, Alves A, Nousbaum JB, Reboux N. Predictors of Survival in Elderly Patients [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/publications\/articles-originaux\/\" \/>\n<meta property=\"og:site_name\" content=\"REGISTRE DES TUMEURS DIGESTIVES DU FINISTERE\" \/>\n<meta property=\"article:modified_time\" content=\"2023-02-06T21:22:12+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"10 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/publications\/articles-originaux\/\",\"url\":\"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/publications\/articles-originaux\/\",\"name\":\"Articles originaux - REGISTRE DES TUMEURS DIGESTIVES DU FINISTERE\",\"isPartOf\":{\"@id\":\"https:\/\/registre-tumeurs-29.fr\/Accueil\/#website\"},\"datePublished\":\"2015-08-05T16:29:19+00:00\",\"dateModified\":\"2023-02-06T21:22:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/publications\/articles-originaux\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/publications\/articles-originaux\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/publications\/articles-originaux\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/registre-tumeurs-29.fr\/Accueil\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Publications et communications\",\"item\":\"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Publications\",\"item\":\"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/publications\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Articles originaux\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/registre-tumeurs-29.fr\/Accueil\/#website\",\"url\":\"https:\/\/registre-tumeurs-29.fr\/Accueil\/\",\"name\":\"REGISTRE DES TUMEURS DIGESTIVES DU FINISTERE\",\"description\":\"Equipe d&#039;Accueil EA 7479 SPURBO - Soins Primaires, Sant\u00e9 Publique et Registre des cancers de Bretagne Occidentale\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/registre-tumeurs-29.fr\/Accueil\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Articles originaux - REGISTRE DES TUMEURS DIGESTIVES DU FINISTERE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/publications\/articles-originaux\/","og_locale":"fr_FR","og_type":"article","og_title":"Articles originaux - REGISTRE DES TUMEURS DIGESTIVES DU FINISTERE","og_description":"Badic B, Morvan M, Qu\u00e9n\u00e9herv\u00e9 L, Bouzeloc S, Kermarrec T, Nousbaum JB, Reboux N.\u00a0Real World Data for Pancreatic Adenocarcinoma from a Population-Based Study in France.\u00a0Cancers (Basel). 2023 Jan 15;15(2):525. doi: 10.3390\/cancers15020525.PMID: 36672474 (Pubmed) Badic B, Bouvier AM, Bouvier V, Morvan M, Jooste V, Alves A, Nousbaum JB, Reboux N. Predictors of Survival in Elderly Patients [&hellip;]","og_url":"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/publications\/articles-originaux\/","og_site_name":"REGISTRE DES TUMEURS DIGESTIVES DU FINISTERE","article_modified_time":"2023-02-06T21:22:12+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"10 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/publications\/articles-originaux\/","url":"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/publications\/articles-originaux\/","name":"Articles originaux - REGISTRE DES TUMEURS DIGESTIVES DU FINISTERE","isPartOf":{"@id":"https:\/\/registre-tumeurs-29.fr\/Accueil\/#website"},"datePublished":"2015-08-05T16:29:19+00:00","dateModified":"2023-02-06T21:22:12+00:00","breadcrumb":{"@id":"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/publications\/articles-originaux\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/publications\/articles-originaux\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/publications\/articles-originaux\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/registre-tumeurs-29.fr\/Accueil\/"},{"@type":"ListItem","position":2,"name":"Publications et communications","item":"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/"},{"@type":"ListItem","position":3,"name":"Publications","item":"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/publications\/"},{"@type":"ListItem","position":4,"name":"Articles originaux"}]},{"@type":"WebSite","@id":"https:\/\/registre-tumeurs-29.fr\/Accueil\/#website","url":"https:\/\/registre-tumeurs-29.fr\/Accueil\/","name":"REGISTRE DES TUMEURS DIGESTIVES DU FINISTERE","description":"Equipe d&#039;Accueil EA 7479 SPURBO - Soins Primaires, Sant\u00e9 Publique et Registre des cancers de Bretagne Occidentale","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/registre-tumeurs-29.fr\/Accueil\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/registre-tumeurs-29.fr\/Accueil\/wp-json\/wp\/v2\/pages\/96","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/registre-tumeurs-29.fr\/Accueil\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/registre-tumeurs-29.fr\/Accueil\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/registre-tumeurs-29.fr\/Accueil\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/registre-tumeurs-29.fr\/Accueil\/wp-json\/wp\/v2\/comments?post=96"}],"version-history":[{"count":42,"href":"https:\/\/registre-tumeurs-29.fr\/Accueil\/wp-json\/wp\/v2\/pages\/96\/revisions"}],"predecessor-version":[{"id":2148,"href":"https:\/\/registre-tumeurs-29.fr\/Accueil\/wp-json\/wp\/v2\/pages\/96\/revisions\/2148"}],"up":[{"embeddable":true,"href":"https:\/\/registre-tumeurs-29.fr\/Accueil\/wp-json\/wp\/v2\/pages\/90"}],"wp:attachment":[{"href":"https:\/\/registre-tumeurs-29.fr\/Accueil\/wp-json\/wp\/v2\/media?parent=96"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}